1.
Guetter CR, Badreg AM, Martinez C, Moura DL, Espinoza EA, Krause FP, Vismara L, Godoy LC, Serrano ML, Sampaio PHM de A, Batista RS, Illigens BM-W. Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol. PPCR [Internet]. 2018 Jul. 25 [cited 2024 Sep. 20];4(1):14-20. Available from: https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/53